Miller Mary
Insider CIK 1841088 · ACRV Chief Legal Officer · BFLY General Counsel & Corp Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-10-22 | 2026-10-26 | 513 | $1.84 | $944 | 81,202 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-10-05 | 2026-10-07 | 294 | $1.99 | $585 | 81,715 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 185 | $2.01 | $372 | 82,009 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 185 | $2.01 | $372 | 82,009 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-07-21 | 2026-07-23 | 573 | $1.76 | $1.0K | 82,194 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 49,830 | — | $0 | 82,767 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-05-14 | 2026-05-18 | 184 | $1.92 | $353 | 32,937 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-04-17 | 2026-04-21 | 558 | $1.78 | $993 | 33,121 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 129,760 | — | $0 | 129,760 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-02-14 | 2026-02-18 | 217 | $1.63 | $354 | 33,679 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2026-01-17 | 2026-01-21 | 659 | $1.98 | $1.3K | 33,896 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-11-14 | 2025-11-18 | 184 | $2.24 | $412 | 34,555 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-10-17 | 2025-10-21 | 558 | $1.81 | $1.0K | 34,739 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-10-01 | 2025-10-03 | 284 | $1.81 | $514 | 35,297 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-08-14 | 2025-08-18 | 184 | $1.39 | $256 | 35,581 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-07-17 | 2025-07-21 | 558 | $1.32 | $737 | 35,765 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-05-14 | 2025-05-16 | 184 | $1.14 | $210 | 36,323 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-04-17 | 2025-04-18 | 558 | $1.81 | $1.0K | 36,507 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 15,616 | — | $0 | 15,616 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-03-01 | 2025-03-04 | 93,693 | — | $0 | 93,693 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-02-14 | 2025-02-19 | 217 | $5.42 | $1.2K | 37,065 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-01-17 | 2025-01-22 | 659 | $5.78 | $3.8K | 37,282 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-11-14 | 2024-11-18 | 184 | $7.92 | $1.5K | 37,941 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-10-17 | 2024-10-21 | 558 | $7.87 | $4.4K | 38,125 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-10-01 | 2024-10-03 | 284 | $6.98 | $2.0K | 38,683 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-08-14 | 2024-08-16 | 184 | $7.02 | $1.3K | 38,967 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-07-17 | 2024-07-19 | 558 | $7.69 | $4.3K | 39,151 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-05-14 | 2024-05-16 | 184 | $8.36 | $1.5K | 39,709 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-04-17 | 2024-04-19 | 558 | $10.34 | $5.8K | 39,893 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-11-27 | 67,567 | — | $0 | 67,567 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-02-14 | 2024-02-16 | 217 | $3.40 | $738 | 40,451 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2024-01-17 | 2024-01-19 | 652 | $4.35 | $2.8K | 40,668 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2023-11-14 | 2023-11-16 | 735 | $5.08 | $3.7K | 41,320 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2023-10-17 | 2023-10-19 | 2,232 | $5.48 | $12.2K | 42,055 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2023-09-26 | 2023-09-28 | 11,576 | — | $0 | 11,576 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2023-09-26 | 2023-09-28 | 3,858 | — | $0 | 44,287 | SEC↗ |
| BFLY Butterfly Network, Inc. | A Award | 2022-03-22 | 2022-03-24 | 54,789 | — | $0 | 383,512 | SEC↗ |
| BFLY Butterfly Network, Inc. | A Award | 2022-03-04 | 2022-03-08 | 189,655 | — | $0 | 328,723 | SEC↗ |
| BFLY Butterfly Network, Inc. | S Sale | 2022-02-16 | 2022-02-17 | 16,677 | $5.95 | $99.2K | 139,068 | SEC↗ |
| BFLY Butterfly Network, Inc. | A Award deriv | 2021-02-12 | 2021-02-16 | 259,575 | — | $0 | 259,575 | SEC↗ |
| BFLY Butterfly Network, Inc. | A Award deriv | 2021-02-12 | 2021-02-25 | 259,575 | — | $0 | 259,575 | SEC↗ |
| BFLY Butterfly Network, Inc. | A Award | 2021-02-12 | 2021-02-25 | 155,745 | — | $0 | 155,745 | SEC↗ |